UK recognises Indian vaccine certificate: No quarantine for Covishield-vaccinated travellers from Oct 11
3 years, 2 months ago

UK recognises Indian vaccine certificate: No quarantine for Covishield-vaccinated travellers from Oct 11

India Today  

On Thursday, UK announced that fully vaccinated Indian travellers will no longer have to quarantine on entering the country. Alex Ellis, British High Commissioner to India, posted from his official Twitter handle, "No quarantine for Indian travellers to UK fully vaccinated with Covishield or another UK-approved vaccine from 11 October. No quarantine for Indian travellers to UK fully vaccinated with Covishield or another UK-approved vaccine from 11 October. QUICK RECAP Earlier, amid a row between India and UK over the latter not recognising India's Covishield vaccine, the UK had amended its travel rules and said that it recognises Covishield as a Covid-19 vaccine. In September, External Affairs Minister S Jaishankar had taken up the issue of Covishield-vaccinated travellers being required to quarantine in the UK with newly-appointed British Foreign Secretary Elizabeth Truss at a meeting in New York.

India Quarantine Indian Oct Vaccine Vaccinated Indian Travellers Covishield No Quarantine  vaccine  uks  quarantine  uk  travellers  oct  vaccinated  covishield  india  vaccination  covishieldvaccinated  certificate  11  indian  recognises

History of this topic

Covid vaccine: How to book a jab and who is eligible?
2 months ago

Covid vaccine: How to book a jab and who is eligible?

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. UKHSA figures showed the admission rate for patients testing …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
7 months, 2 weeks ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

Stopped manufacturing Covishield since December 2021, says Serum Institute
7 months, 2 weeks ago

Stopped manufacturing Covishield since December 2021, says Serum Institute

Hindustan Times  

Pune-based Serum Institute of India stopped manufacturing its anti-Covid-19 vaccine Covishield in 2021, according to a statement issued by the company on Wednesday after British-Swedish pharmaceutical manufacturer AstraZeneca announced it was withdrawing its vaccine against Covid, Vaxzevria, due to “commercial reasons” as demand for it decreased globally. Consequently, since December 2021, we have stopped the manufacturing and supply of additional …

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’
7 months, 3 weeks ago

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’

The Hindu  

The controversy over the safety aspects of the Covishield vaccine reached the Supreme Court on Wednesday, May 1, 2024, with a petition seeking the constitution of an expert medical panel to study the risk factors. Now after the document filed in UK court by the developer of Covishield, we are compelled to think on the risk and hazardous consequences of …

Covishield more effective than Covaxin: Study
9 months, 2 weeks ago

Covishield more effective than Covaxin: Study

New Indian Express  

BENGALURU: Covishield vaccine had higher antibody response compared to Covaxin during the pandemic, according to a study by a consortium of 11 institutions led by scientists from the National Centre for Biological Sciences, Bengaluru. In all, 691 people aged between 18 and 45, mostly from Bengaluru and Pune, were part of the study.’Immunogenicity of SARS - CoV-2 vaccines Covaxin and …

New COVID variant JN.1: Health Ministry says no need for booster dose
1 year ago

New COVID variant JN.1: Health Ministry says no need for booster dose

The Hindu  

Following the Union Health Ministry direction that States be alert and prepared for any possible surge in COVID-19 cases following the emergence of the new variant JN.1, senior health officials said that there is no move to recommend administration of vaccine booster dose for India. India saw a single-day rise of 656 COVID-1 infections while the active cases have increased …

Covid in India Highlights: Maharashtra reports nine JN.1 infections
1 year ago

Covid in India Highlights: Maharashtra reports nine JN.1 infections

Hindustan Times  

Covid in India Highlights: India logged a total of 656 fresh cases of Covid-19 infections on December 24. Former AIIMS, Delhi, director Randeep Guleria said the sub-variant JN.1 is “gradually becoming dominant” but observed that it is not causing severe infections or hospitalisations. The World Health Organisation also classified JN.1 into the Variant of Interest category, however, said there is …

COVID returns? Hospitalisation hits record high in THIS country | DEETS INSIDE
1 year, 2 months ago

COVID returns? Hospitalisation hits record high in THIS country | DEETS INSIDE

India TV News  

As winter approaches, health authorities in the United Kingdom have issued a warning for its citizens to prepare for another wave of COVID-19. UK Health Security Agency has claimed that the cases will 'further increase' as the season progresses, along with other 'winter respiratory viruses like flu'. As we enter the colder months and people begin to mix more indoors, …

Covid vaccine: Over-65s urged to get booster jabs as hospital cases rise
1 year, 3 months ago

Covid vaccine: Over-65s urged to get booster jabs as hospital cases rise

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} The NHS …

New Covid variant Eris detected in Maharashtra; should India be worried? What experts say
1 year, 4 months ago

New Covid variant Eris detected in Maharashtra; should India be worried? What experts say

Hindustan Times  

New Covid variant EG.5.1 or Eris that has been adding to the surge of Coronavirus cases in UK has also been causing slight increase in Coronavirus caseload in Maharashtra. The new Covid strain Eris has increased hospitalisation cases among elderly in UK and while there is no need to panic, it's imperative to keep a close watch on it. The …

Serum Institute could resume Covishield production as Covid cases rise
1 year, 8 months ago

Serum Institute could resume Covishield production as Covid cases rise

Live Mint  

The Serum Institute of India could resume production of the Covishield Covid-19 vaccine as infections rise in the country, a company spokesperson said on Wednesday. Dr Amitav Banerjee - an epidemiologist who leads DY Patil Medical College in Pune has earlier said that Covishield carried a ‘double whammy of risk’. Many would perhaps not know that Covishield carries a DNA …

England rolls out spring Covid-19 booster shots for vulnerable groups
1 year, 8 months ago

England rolls out spring Covid-19 booster shots for vulnerable groups

Firstpost  

The National Health Service said others eligible can book in on the UK’s National Booking Service or the NHS App from next Wednesday, with the first appointments available from April 17 London: Around five million people in England will be eligible for a spring Covid-19 booster vaccine, including over 75-year-olds, those with a weakened immune system, and care home residents, …

’Covishield shouldn’t have been rolled out’: Doctor flags ’severe’ side-effects
1 year, 10 months ago

’Covishield shouldn’t have been rolled out’: Doctor flags ’severe’ side-effects

Live Mint  

A well known British-Indian cardiologist has flagged the cardiovascular side effects of the Covishield vaccine. According to Dr Aseem Malhotra, the vaccine manufactured in India by the Serum Institute is ‘even worse’ than mRNA COVID-19 vaccines when it came to concerns such as heart attacks and strokes. Citing a comparison published in a peer-reviewed journal, he said that the Oxford-AstraZeneca …

Braving a Viral Storm tells the tale of India’s COVID vaccine journey
1 year, 11 months ago

Braving a Viral Storm tells the tale of India’s COVID vaccine journey

The Hindu  

India’s development and production of its own vaccines against COVID-19 was an important part of dealing with the pandemic, pushed by Prime Minister Narendra Modi’s view that the “entrepreneurial state” of government would bear the front-loaded risks of the effort, cushioning the private sector, according to a new book. The authors of Braving a Viral Storm: India’s Covid-19 Vaccine Story, …

Could the UK impose new Covid travel restrictions?
1 year, 11 months ago

Could the UK impose new Covid travel restrictions?

The Independent  

Sign up to Simon Calder’s free travel email for expert advice and money-saving discounts Get Simon Calder’s Travel email Get Simon Calder’s Travel email SIGN UP I would like to be emailed about offers, events and updates from The Independent. “Pre-departure testing and the requirement to show a negative test result has been shown to decrease the number of infected …

Fourth Covid vaccine unwarranted right now but increased surveillance needed: experts
1 year, 11 months ago

Fourth Covid vaccine unwarranted right now but increased surveillance needed: experts

Deccan Chronicle  

NEW DELHI: Several countries are administering a third and even fourth Covid booster shot but India, where many fully vaccinated individuals have not taken even one, is not there yet, say experts while stressing on the need for a structured and systematic response. If that infection did not trigger enough Omicron-specific immunity none of the vaccines currently available in India …

India's move to conduct random RT-PCR tests unlikely to disrupt travel plans of holidaymakers
1 year, 11 months ago

India's move to conduct random RT-PCR tests unlikely to disrupt travel plans of holidaymakers

The Hindu  

India's move to conduct RT-PCR test on a limited scale on passengers arriving from abroad has raised concerns among travellers but it's unlikely to have disruptive impact on the travel plans of most holidaymakers, including from the diaspora, the community members said on December 25, 2022. The Indian government on Saturday ramped up anti-COVID measures in the wake of a …

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
2 years ago

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN

Firstpost  

The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening New Delhi: Bharat Biotech’s intranasal COVID-19 vaccine has been approved by the Ministry of Health and Family Welfare for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. …

Indian Army issues advisory on Covid, asks defence personnel to take safety measures
2 years ago

Indian Army issues advisory on Covid, asks defence personnel to take safety measures

India TV News  

The Indian Army issued an advisory on Friday asking defence personnel to take up adequate measures to tackle COVID. The advisory asked them to take up measures such as the usage of face masks in closed or crowded places, practising hand sanitisation, and maintaining social distancing among others. Union Health Minister Dr Mansukh Mandaviya is set to hold a virtual …

India need not panic given excellent COVID-19 vaccination coverage: Adar Poonawalla
2 years ago

India need not panic given excellent COVID-19 vaccination coverage: Adar Poonawalla

The Hindu  

Serum Institute of India CEO Adar Poonawalla on Tuesday expressed concern over reports of a rising COVID-19 graph in China but said there is no need to panic as the vaccination coverage in India is excellent. Mr. Poonawalla's tweet came a day after the Union Health Ministry urged all states and UTs to ramp up the whole genome sequencing of …

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget
2 years, 2 months ago

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget

The Hindu  

The government’s COVID-19 vaccination programme is in its final leg with the Health Ministry deciding against procuring more vaccines as of now and surrendering ₹4,237 crore, or nearly 85% of the 2022-23 budget allocation for inoculation purposes, to the Finance Ministry. Official sources told PTI that more than 1.8 crore doses are still available with the governments at the Centre …

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically
2 years, 4 months ago

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically

News 18  

Individuals who have received Covid-19 vaccines abroad and wish to get their second dose or booster shot in India can now do so. The development comes following an August 18 report by the Times of India which highlighted the issues people who had been jabbed abroad faced when they tried to receive a second or third shot here because the …

COVID-19: Corbevax to be given as boosters at vaccination centres from today
2 years, 4 months ago

COVID-19: Corbevax to be given as boosters at vaccination centres from today

Live Mint  

Hyderabad based-Biological E Ltd 's recently approved heterologous Covid-19 vaccine Corbevax to be available as a booster dose on the COWIN App in both public and private vaccination centres from 12 August, the firm said on 11 August. The Union Health Ministry approved Corbevax as India's first heterologous COVID-19 booster shot for 18 years and above after the six months …

Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday
2 years, 4 months ago

Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday

News 18  

Biological E. Ltd on Thursday said it has delivered 10 crore doses of its Covid-19 vaccine, Corbevax to the Centre so far which is expected to be available as a booster dose on the Cowin App in public and private vaccination centers from Friday. Corbevax was also approved by the Union Health Ministry as a heterologous Covid-19 booster dose under …

Corbevax as Covid booster for adults from August 12. Check details
2 years, 4 months ago

Corbevax as Covid booster for adults from August 12. Check details

India Today  

In a boost to India’s fight against coronavirus, the government gave nod to Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Announcing the decision, Union Health minister Mansukh Mandaviya said, “Further Strengthening India's arsenal against Covid-19, Ministry of Health and Family Welfare approves Corbevax as precaution dose for those …

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report
2 years, 4 months ago

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report

Live Mint  

The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, news agency PTI has reported on 10 August citing official sources. "Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of …

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients
2 years, 4 months ago

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients

News 18  

The Centre has approved Biological E’s Corbevax as a Covid-19 precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Union Health Secretary Rajesh Bhushan said, “Corbevax will be available as precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines …

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon
2 years, 4 months ago

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon

News 18  

The Union health ministry is expected to soon approve Biological E’s Corbevax as a precaution dose for people above 18 years who are double vaccinated with either Covishield or Covaxin, official sources said on Tuesday. “Corbevax will be considered as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second dose …

Travelling to India from abroad? Govt mulls doing away with this rule
2 years, 4 months ago

Travelling to India from abroad? Govt mulls doing away with this rule

Live Mint  

So all those planning to travel to India from abroad, please be informed about the changes in the new rule which the government is actively considering. As of now, passengers are required to upload their Covid-19 vaccine certificate or RT-PCR negative report on the Air Suvidha portal before coming to India. "The Civil Aviation Ministry recently sought inputs from the …

Adults may get different vaccine as booster shot instead of Covishield, Covaxin
2 years, 4 months ago

Adults may get different vaccine as booster shot instead of Covishield, Covaxin

Live Mint  

As the government has continued to emphasize Covid booster doses due to the rising number of cases, a panel has recommended a different vaccine for Indian adults. Government panel National Technical Advisory Group on Immunisation has recommended Biological E's Corbevax as a precaution dose for adults fully vaccinated with either Covishield or Covaxin. "Corbevax may be considered for a third/precaution …

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre
2 years, 5 months ago

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre

Firstpost  

Minister of State for Health Bharati Pravin Pawar said as on 19 July, 2022, a total of 200.34 crore COVID-19 vaccine doses have been administered to beneficiaries above 12 years of age in the country New Delhi: India has supplied 23.9 crore doses of coronavirus vaccine to 101 countries and UN entities in the form of grant, commercial export, or …

India's Covid Vaccinations Hit 200 Crore Mark in Big Milestone for 7-Phase Drive Under Modi's Leadership
2 years, 5 months ago

India's Covid Vaccinations Hit 200 Crore Mark in Big Milestone for 7-Phase Drive Under Modi's Leadership

News 18  

India has crossed record 200 crore mark in Covid-19 vaccinations within 18 months of launching the inoculation exercise in January last year. #200CroreVaccinations https://t.co/FtobFYBprV— Dr Mansukh Mandaviya July 17, 2022 A seven-phase vaccination drive was followed on the principle of Prioritization for Vaccine Administration based on scientific advice and global best practices, government officials told News18. While some experts had …

DC Edit | A good move, as Covid cases up
2 years, 5 months ago

DC Edit | A good move, as Covid cases up

Deccan Chronicle  

The decision of the Union government to push the vaccination programme further against Covid-19 by making the precaution dose free for those who are aged above 18 years has come not one day sooner. That only one per cent of the eligible population aged between 18 and 59 has got the precaution dose calls on the government to redouble its …

Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered by NTAGI
2 years, 5 months ago

Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered by NTAGI

The Hindu  

Allowing Biological E’s Corbevax as a booster for those fully vaccinated against COVID-19 with either Covishield or Covaxin is likely to be considered by the NTAGI, which is scheduled to meet on Tuesday, sources said. “The National Technical Advisory Group on Immunisation will discuss allowing Corbevax, which has been cleared by the DCGI, as a booster for those fully vaccinated …

UK-India Relationship Has Emerged Stronger Than Ever After the Covid Turbulence
2 years, 5 months ago

UK-India Relationship Has Emerged Stronger Than Ever After the Covid Turbulence

News 18  

With the UK-India week on the cusp, it becomes pertinent to discuss how the United Kingdom and India have weathered rough storms during the pandemic years to come out closer than ever. It is this three-way partnership that has now been at the helm of having already delivered over 2 billion affordable, effective vaccines which have now been administered to …

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study
2 years, 6 months ago

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study

The Hindu  

COVID-19 vaccines prevented over 42 lakh potential deaths in India in 2021, said a study published in The Lancet Infectious Diseases journal, which based its findings on estimates of "excess" mortalities in the country during the pandemic. In the first year of the vaccination programme, 19.8 million out of a potential 31.4 million COVID-19 deaths were prevented worldwide, according to …

Corbevax gets DCGI nod as COVID-19 booster after two doses of Covishield or Covaxin
2 years, 6 months ago

Corbevax gets DCGI nod as COVID-19 booster after two doses of Covishield or Covaxin

The Hindu  

Hyderabad-based Biological E. Limited ’s COVID-19 vaccine Corbevax has been approved by the Drug Controller General of India as a heterologous COVID-19 booster dose to individuals aged 18 years and above after 6 months of administration of primary vaccination of Covaxin or Covishield vaccines for restricted use in emergency situations. ‘’Recently, BE furnished its clinical trials data to the DCGI, …

Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above
2 years, 6 months ago

Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above

ABP News  

New Delhi: The Drug Controller General of India approved the Corbevax Covid-19 booster as heterologous Covid-19 booster dose for adults above the age of 18 years who got their primary Covid-19 vaccination of Covishield or Covaxin administered six months before, reported news agency ANI. Recently, BE has furnished its clinical trials data to the DCGI who after a detailed evaluation …

Corbevax gets DCGI nod as Covid-19 booster dose
2 years, 6 months ago

Corbevax gets DCGI nod as Covid-19 booster dose

India TV News  

Highlights Biological E's Corbevax vaccine has been cleared for a booster dose for those 18 and above. The Drugs Controller General Of India had earlier approved Corbevax, India's first indigenously developed RBD protein subunit vaccine, for restricted use in emergency situations for those aged five and above.A press release from the vaccine maker said the Corbevax can be administered as …

Mix and match of Covid vaccine for booster shots unlikely to be allowed: Report
2 years, 7 months ago

Mix and match of Covid vaccine for booster shots unlikely to be allowed: Report

Live Mint  

The government may not allow the administration of a precaution Covid-19 dose that is different from the one used for primary vaccination, reported news agency PTI, quoting sources, on Thursday. This comes in light of a recent study by the Christian Medical College Vellore, which showed that a booster dose of Covishield after primary vaccination with Covaxin gives 6 to …

Gap Between 2nd Covid Vaccine, Booster Dose Reduced To 3 Months For Those Travelling Abroad
2 years, 7 months ago

Gap Between 2nd Covid Vaccine, Booster Dose Reduced To 3 Months For Those Travelling Abroad

ABP News  

New Delhi: The government has now reduced the gap between second Covid-19 vaccine jab and booster dose to a minimum of 90 days for those travelling abroad, news agency PTI reported quoting official sources on Wednesday. Those who need to travel overseas can take the booster dose of Covid vaccine as required by the country they are travelling to before …

Jabs for Kids, Reducing Gap Between Doses for Those Travelling Abroad on Agenda as NTAGI Meets Today
2 years, 7 months ago

Jabs for Kids, Reducing Gap Between Doses for Those Travelling Abroad on Agenda as NTAGI Meets Today

News 18  

As India witnesses a surge in coronavirus cases once again, the Covid-19 working group of the National Technical Advisory Group on Immunisation will meet at noon on Wednesday to discuss reducing the gap between the second dose and the precaution dose for people traveling abroad as well as vaccinations for 5-12 and 6-12 age groups. Last week, India’s drug regulator …

No Haste In Granting Emergency Use Authorization To Covaxin & Covishield: Supreme Court
2 years, 7 months ago

No Haste In Granting Emergency Use Authorization To Covaxin & Covishield: Supreme Court

Live Law  

In its judgment holding that the policy of the Union Government on COVID-19 vaccination policy is reasonable, the Supreme Court rejected the contention that restricted emergency use approvals had been granted to COVISHIELD and COVAXIN in haste, without thorough review of the relevant data.The court observed that the challenge to the procedures adopted by the expertbodies while granting. "However, it …

In haste: The Hindu Editorial on vaccinating children against COVID-19
2 years, 7 months ago

In haste: The Hindu Editorial on vaccinating children against COVID-19

The Hindu  

The emergency use authorisation granted on April 26 to two COVID-19 vaccines — Corbevax for children 5-11 years, and Covaxin for children 6-11 years — is one more instance where the Indian drug regulator has acted in haste. Even if the EUA granted to Covaxin in January 2021 despite no safety and efficacy data of the phase-3 trial is condoned …

Govt panel approves use of Corbevax for 5-12 year age group
2 years, 8 months ago

Govt panel approves use of Corbevax for 5-12 year age group

India Today  

Expert panel of Drug Controller General of India -- India’s drug regulator-- has recommended granting emergency use authorisation for Biological E's Covid-19 vaccine Corbevax for children in 5 to 12 years age group. "The Subject Expert Committee on COVID-19 of the CDSCO which deliberated on Biological E's EUA application has recommended granting emergency use authorisation for use of Corbevax in …

Indian Covid vaccines better than Pfizer, Moderna, says Adar Poonawalla
2 years, 8 months ago

Indian Covid vaccines better than Pfizer, Moderna, says Adar Poonawalla

India Today  

Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that Covid-19 vaccines that are made in India, have provided more protection against coronavirus infection than vaccines like Pfizer and Moderna. Speaking to news agency ANI, Poonawalla said, "The Covid-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and …

COVID-19: Indian vaccines better than Pfizer, Moderna, says Adar Poonawalla
2 years, 8 months ago

COVID-19: Indian vaccines better than Pfizer, Moderna, says Adar Poonawalla

Firstpost  

The COVID-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and Moderna, said Adar Poonawalla New Delhi: Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that “Made in India” COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna. “The …

Covid-19 precaution dose for 18+ age group from today. Check eligibility, price and how to book
2 years, 8 months ago

Covid-19 precaution dose for 18+ age group from today. Check eligibility, price and how to book

India Today  

From Sunday onwards, all adults in the country are eligible to get booster vaccine doses against Covid-19, the central government had announced earlier this week. The Covid-19 precaution doses or booster shots will be available for all adults at private vaccination centres and will be administered on payment of a fee. PRICE Except for healthcare workers, frontline workers and the …

India approves ‘precaution’ doses of COVID-19 vaccine for all over 18 from April 10
2 years, 8 months ago

India approves ‘precaution’ doses of COVID-19 vaccine for all over 18 from April 10

The Hindu  

The Union Health Ministry on Friday announced that the precautionary or third dose of COVID-19 vaccine would be made available to the 18+ population at private vaccination centres. 1,109 new infections The decision comes even as India logged 1,109 new coronavirus infections taking the total tally of COVID-19 cases to 4,30,33,067,while the active cases dipped to 11,492, according to the …

‘Anti-science extremist’: Tory MP shut down for claiming Covid jabs ‘disaster in the making’
2 years, 8 months ago

‘Anti-science extremist’: Tory MP shut down for claiming Covid jabs ‘disaster in the making’

The Independent  

Sign up for the View from Westminster email for expert analysis straight to your inbox Get our free View from Westminster email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} A Tory MP …

Discover Related